Liver tumour ablation nowadays represents a routine treatment option for patients with primary and secondary liver tumours. Radiofrequency ablation and microwave ablation are the most widely adopted methods, although novel techniques, such as irreversible electroporation, are quickly working their way up. The percutaneous approach is rapidly gaining popularity because of its minimally invasive character, low complication rate, good efficacy rate, and repeatability. However, matched to partial hepatectomy and open ablations, the issue of ablation site recurrences remains unresolved and necessitates further improvement. For percutaneous liver tumour ablation, several realtime imaging modalities are available to improve tumour visibility, detect surrounding critical structures, guide applicators, monitor treatment effect, and, if necessary, adapt or repeat energy delivery. Known predictors for success are tumour size, location, lesion conspicuity, tumourfree margin, and operator experience. The implementation of reliable endpoints to assess treatment efficacy allows for completionprocedures, either within the same session or within a couple of weeks after the procedure. Although the effect on overall survival may be trivial, (local) progression-free survival will indisputably improve with the implementation of reliable endpoints. This article reviews the available needle navigation techniques, evaluates potential treatment endpoints, and proposes an algorithm for quality control after the procedure.
With hepatocellular carcinoma (HCC) being the third leading cause of cancer deaths worldwide and colorectal cancer as the second most common cause of cancer-related mortality in developed countries, primary and secondary malignant liver tumours are very frequently encountered. About 40%e76% of colorectal cancer patients develop colorectal liver metastases (CRLMs) in the course of their disease [1, 2] . Although gradually shifting, surgical resection is still considered the gold standard for curative intent treatment of hepatic malignancies. However, the majority of patients (80%e90%) [2, 3] cannot undergo partial hepatectomy because of: 1) an impaired general health status; 2) a history of extensive abdominal surgery; 3) early or rapid disease progression; 4) the presence of lesions in an anatomical unfavorable location; or 5) an insufficient future liver remnant to resect all lesions [1,4e6] . Given the negligible ablation site recurrence rate for small ( 2 cm) HCCs, the well-known international Barcelona Clinic Liver Cancer staging system has replaced surgical resection with percutaneous ablation as primary treatment option [7e15] . Similarly, surgery for small ( 3 cm) CRLMs is currently being challenged in 2 large ongoing phase III trials from the Netherlands (the COLLISION [Colorectal Liver Metastases: Surgery vs Thermal Ablation] trial, low-risk patients; NCT03088150) and the United Kingdom (LAVA [Liver Resection Surgery vs Thermal Ablation for Colorectal Liver Metastases] trial, high-risk patients; ISRCTN52040363).
Over the past 2 decades thermal ablation techniques, such as radiofrequency ablation (RFA) and microwave ablation (MWA), have become auspicious treatment options for patients with hepatic malignancies due to their minimal invasiveness, good and still improving efficacy, potential for repeated ablations, and low costs [16e23] . Irreversible electroporation (IRE) is a novel, predominantly nonthermal, ablation technique that is increasingly investigated for liver tumours near major bile ducts and blood vessels.
Preprocedural staging and treatment planning is quintessential to assess treatment success. Similar to routine workup before partial hepatectomy, at minimum a contrast-enhanced computed tomography (CECT) is required. Routinely performing contrast-enhanced magnetic resonance imaging (MRI) with liver-specific contrast agents such as gadoxetate disodium (Primovist), plus high B-value MR diffusionweighted imaging (DWI) has proven to reduce intrahepatic recurrence and, therefore, the need for repeat procedures [24] . The use of 2-[18F]-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography (PET) CT may also be indicated for CRLM patients to exclude extrahepatic disease and to differentiate between malignant and benign lesions. However, specificity is suboptimal for mucinous tumours and poor for patients treated with neoadjuvant chemotherapy [25] .
Assessment of treatment response, during and shortly after the procedure, is crucial to determine treatment outcome and patient safety [26] . Conventional B-mode ultrasound (US) remains the gold standard for performing ablative procedures during laparotomy and, although lesion conspicuity remains a prerequisite, is still commonly used to guide percutaneous procedures [26] . CT and MRI are the most established techniques for percutaneous ablation because they enable acquisition of 3-dimensional images of the tumour in relation to the surrounding structures, the probes and the ablation zone [26, 27] . Nowadays, image fusion, (electromagnetic or infrared) needle tracking, and robotics can provide even more accurate targeting [28] .
Despite technological advances, the primary technique effectiveness (90%e95% for lesions 3 cm and <90% for lesions >3 cm in diameter) should still be considered inadequate and requires further improvements [27] . Technical success depends on several factors such as tumour size, molecular subtype (RAS wild type or mutation) [29] , location, visibility, tumour-free margin, operator experience, and local availability of devoted equipment, such as (virtual) gantry tilt, computer-assisted fusion and navigation techniques, and open MR systems [21,23,30e32] . Sophisticated image-guiding techniques and parameters to evaluate treatment success directly after or within the first weeks after ablation (allowing for completion procedures) will likely improve outcome. Although the effect on overall survival may be trivial [33] , local progression-free and disease-free survival will indisputably increase.
This article reviews currently available image-guiding techniques for percutaneous ablation of liver malignancies, provides an overview of methods to determine technical success, and suggests an algorithm for quality control.
Image-Guiding Techniques and Needle Navigation
In percutaneous ablation, adequate imaging is crucial for: 1) preprocedural planning; 2) intraprocedural targeting (needle guidance or catheter delivery); 3) intraprocedural monitoring (real-time imaging of tissue changes resulting from treatment); 4) intraprocedural modification (real-time ability to make adjustments); and 5) postprocedural assessment (measurement of treatment effectiveness and need for further intervention) [23, 26] . Different imaging techniques can be used, solitarily or in combination, to successfully perform each of these steps ( Table 1) .
A successful procedure can be achieved by ablation that covers the complete tumour volume plus a certain tumourfree margin without harming nearby critical structures. Therefore, optimal imaging modalities should provide anatomical 3-dimensional (3D) images to depict the target, surrounding structures, and the interventional probes, as well as physiological information indicative for the ablated volume, such as alterations in echogenicity, signal attenuation, contrast enhancement, or metabolic activity. Although present-day imaging systems provide some of these characteristics, none provide all of them [23] .
Transcutaneous Ultrasound
Conventional B-mode US is the most widely used realtime imaging technique, mainly because it is cheap, fast, easy to use, repeatable, and does not require ionizing radiation [5,22,33e36] . However, visualization of the target lesion can be poor (sensitivity around 55%) due to (deeper) location, small size, obscuration by overlying structures, impediment by gas formation at the ablation zone, liver cirrhosis, and low echogenicity gradient [35e38]. Interestingly, with IRE the ablation zone will become hypoechoic, as opposed to the well-known hyperechoic ablation zone following RFA and MWA (Figures 1 and 2 ). Contrastenhanced US (CEUS) increases lesion conspicuity and provides better real-time visibility of the target, needle placement, and safety margins [21, 36, 39, 40] . Normally, probe placement below the costal margin increases operating difficulties due to interference of intrapulmonary gas. US combined with artificial pleural effusion provides better visibility for hepatic malignancies located near the diaphragm [41] .
Computed Tomography
CECT guidance plus fluoroscopy enables a 3D view of the target tumour, surrounding structures, needle(s), and the ablation zone ( Figure 3 ) [23, 42] . This guidance modality is associated with a high technical success rate, a fair technique efficacy, and a low complication rate [43, 44] . Important disadvantages of CT fluoroscopy are high radiation exposure to patients and physicians, limited angle of needle insertion, and suboptimal visualization of intrahepatic vessels.
Magnetic Resonance Imaging
MR-guided liver tumour ablation is known for its near real-time thermal monitoring and is associated with a high sensitivity for small parenchymal lesions [21, 23, 38] . However, some obstacles still remain, such as potentially harmful noise generated during scanning, interference of electrical noise from ablation devices with MRI, and artifacts of instrument visualization. The longer procedure time, higher costs, and restricted availability have limited the use of real-time MRI in clinical practice [23, 45] . Compared with CT-guidance for HCC treatment, MR-guided ablation shows higher primary technique effectiveness which may decrease the number of required sessions for complete tumour treatment [46] .
Fusion Imaging, Needle Tracking, and Robotic Navigation
Image registration refers to the colocalization of one imaging dataset to another on the basis of certain anatomical landmarks. Image fusion refers to the partially transparent overlay of one dataset over another. Rigid registration fuses fixed image datasets, while nonrigid (deformable) registration allows partial image stretching to correct for mismatch caused by target motion or tissue deformation.
In interventional oncology, PET images can be fused with interventional CT or MR images. Preprocedural CT images Table 1 Real-time image-guiding techniques and needle navigation modalities in percutaneous liver tumour ablation may be fused with real-time US. Also, preprocedural MR images may be fused with real-time CT. Nowadays, overlay of fluoroscopic images with rotational angiographic, CT, or MR images is possible. Fusion leads to more accurate 3D targeting and improves conspicuity of smaller (<5 mm) lesions [23,36,47e51] .
In stereotactic ablation, the optimal needle trajectory is planned on a 3D imaging dataset. The dataset is transferred to a workstation where the actual target tissue coordinates are automatically coregistered with the dataset. The target tissue is traced using either an electromagnetic transmitter or infrared markers placed on the patients' skin ( Figure 4 ). The latter is detected using a stationary infrared camera. The needle, also located using electromagnetic waves or infrared marker(s), is projected over the 3D dataset using real-time multiplanar reconstructions [23, 28, 52, 53] . Also, physiologic images (such as 18F-FDG PET) could be merged into an intervention [23] . Stereotactic ablation reduces the number of needle readjustments and can be especially useful for difficult-to-reach areas, such as the hepatic dome [54] .
Robotic navigation can also assist with challenging ablations, especially in those that are out of the axial plane. After entering needle type and length, skin entry site, and target site, the operator moves the table to the recommended z-axis location and the optimal needle angle trajectory is automatically calculated by the planning software. The operator then manually inserts the needle through a needle guide at the end of the robotic arm [23, 28] . 
High-Frequency Jet Ventilation
High-frequency jet ventilation is a mechanical ventilation method where high-flow, short-duration pulses of pressurized gas are delivered in the trachea through a small-calibre catheter [55] . It reduces the amplitude of respiratory movements, and hence liver movements. Although in theory beneficial for percutaneous liver tumour ablation, highfrequency jet ventilation carries a higher risk of barotraumatic pneumothorax.
Transarterial Catheter-Assisted Ablation
One of the most promising new techniques to improve needle targeting is CT arterial portography or hepatic arteriography (CTHA)eguided percutaneous ablation. In CT arterial portography and CTHA an arterial catheter is placed within the superior mesenteric artery or the hepatic artery, respectively. Injecting diluted contrast medium (20 mL:20 mL saline; arterial and early portal venous phase at 7 and 22 seconds from start of injection, respectively) directly into the relevant arteries enables repeated contrastenhanced imaging and real-time CECT fluoroscopy and hence improves: 1) lesion conspicuity; 2) differentiation between ablative scar tissue and vital tumour tissue (incomplete-ring sign); and 3) treatment accuracy at the cost of an additional intervention ( Figures 5 and 6) [27, 56] . In the study by van Tilborg et al [27] mean needle-to-target mismatch distance was 2.4 AE 1.2 mm (range, 0e12.0 mm) and primary technique effectiveness at 3 months was 87% (33 of 38 lesions) for lesions that were undetectable on both US and unenhanced CT.
Endpoints to Assess Technical Success
With most thermal and nonthermal ablation techniques, the endpoint to determine technical success is merely defined as having successfully introduced a certain amount of energy that, according to its preclinical validation in healthy liver parenchyma in animals, is considered to create a certain spherical ablation zone.
However, several characteristics of both targeted liver parenchyma and tumour tissue, such as tissue homogeneity, calcifications, fibrosis, necrosis, cellular and vascular density, and water content, all clearly affect the expanse of tissue injury [23] . Anatomical location and proximity of certain anatomical structures, such as blood vessels, intestines, bile ducts, the diaphragm, and surrounding fatty or other tissue, also play an important role. When the hepatic lesion is located near a large (!3 mm) abutting vessel, heat loss due to perfusion-mediated tissue cooling in the RF ablation zone can occur (heat sink), which protects vessels from bleeding [26, 27, 57] . This heat loss can cause a reduction of up to 50% in tumour necrosis volume and thus denotes an important risk factor for site recurrence [58] .
Tissue Impedance
When tissue temperature rises, blood vessels delivering thermal energy to close regions become carbonized and impedance rapidly rises, hindering further necrosis [59] . To minimize tissue desiccation and charring in RFA, impedance can be controlled by either gradually increasing power or by a stepwise power decrease to avoid early ''roll-off'' [28] . To prevent overheating of the electrode, avoid skin injury, and permit further deposition of energy into tissue with low impedance during ablation, cooled-tip electrodes have been developed [1] . Internally cooled electrodes have an internal lumen, in which a cooling agent (saline, water, or gas) flows without direct contact with tumour tissue. In perfusioncooled electrodes, the tip of the needle has small apertures that allow the cooling agent to be injected into the tissue before, during, or after the procedure [21, 26] .
Tissue Temperature
In RFA, tissue injury is considered to be achieved when the temperature reaches 60 C directly, or remains at 54 C for at least 180 seconds [60] . MWA is not limited by the conductive property of tissues, so higher temperatures can be achieved (>150 C) [31, 57, 58] . The intention of temperature control is to ensure that the maximum energy is applied by using the standard algorithm with the system, which differs among the available devices, and to ensure that surrounding tissue will not be injured, especially for lesions near (<5 mm) vital structures [1] .
Temperature can be monitored indirectly by tissue impedance. The system monitors the needle tip's temperature and delivers peak power until a fixed target temperature is reached. Liver tissue carbonizes and becomes desiccated when the temperature climbs over 100 C (roll-off). Direct monitoring is possible when a target temperature is chosen and power is automatically adjusted to maintain this temperature for a fixed time [26, 59] . Additional temperature monitoring is possible by inserting an extra needle into the target area through a nonconducting trocar [26] .
One randomized controlled trial investigated the efficacy of impedance control of a radiofrequency interstitial thermal ablation system in HCC [59] . Compared with temperature control, the use of impedance control increased the ablated tissue volume and decreased the ablation time.
Imaging Characteristics
Immediate (contrast-enhanced) postablation imaging should demonstrate circumferential coverage of the tumour plus a safety margindat least 5 mm, ideally 10 mmdby the ablation zone [26] . Following thermal ablation, US shows a transient hyperechoic ablation zone that disappears after several minutes ( Figure 1C ). For typical arterial phase hyper-attenuating HCCs, a nonenhancing ablation zone affirms complete ablation on CEUS [21] . A well demarcated, spherical, hypodense ablation zone with a hyperdense peripheral rim (transient periablational hyperemia) can be seen on CECT (Figures 4D and 6C) [21] . MR thermometry is quantitative method of assessing technical success, which enables real-time temperature monitoring by detecting MR imaging proton resonance frequency changes that are associated with temperature change of 1 C. On MRI, the ablation zone after thermal ablation appears as a clear, hyperintense area on T1 (heterogeneous) and T2 (homogeneous) weighted images [23] .
Following IRE the ablation zone is typically hypoechoic on US ( Figure 2C) , hypodense on CECT, and hypointense on T1-weighted images with a hyperattenuating ring on high B-value MR DWI.
Quality Control
The authors refer to quality control if the postprocedural imaging, or any alternative technique, is implemented with the intent to allow for additional overlapping ablations, either within the same procedure or in a complementary completion procedure in the days or weeks hereafter. Initial post-treatment imaging should focus on detecting procedure-related complications and primary treatment failure. Early detection of tumour residue or inadequate margins provides the opportunity to reablate the region and hereby successfully complete the procedure [1, 21, 26, 61] . Nonetheless, differentiation between postablation scar tissue and vital tumour residue can be challenging.
Ultrasound
Reliable differentiation between coagulated and viable tumour tissue is impossible using US. In the first 30 days, the ablation zone slowly decreases in size, appearing as small transient hyperechoic areas or isoechoic areas with a hypoechoic border on US (Table 2) [1, 21] .
For HCCs, tumour residue can be confirmed by residual hypervascularity and a typical washout on CEUS [36, 61] . Within 24 hours after the ablation, CEUS has shown a high accuracy in differentiating reactive periablation perfusion changes from residual HCC tumour tissue [62e64]. However, the hyperattenuating rim along the ablated margins should not be misinterpreted as residual tumour tissue [65] . CEUS can easily be repeated and used to target the residue [64] .
Computed Tomography
Triple-phase CT (unenhanced, late arterial phase, and portal venous phase) remains the mainstay of early routine follow-up and is known for its rapid achievement of a wide range of images and clear comparison to the index tumour [21, 47, 61, 66] . Successful ablation appears as a lower density, nonenhancing area with or without a regular, symmetric, uniform peripheral enhancing rim [21] . In the late arterial phase, peripheral, irregular areas of enhancement near the ablation area are suspect for residual tumour tissue [61] . The ablation zone gradually diminishes in volume [47, 61] .
At about 1e3 weeks postablation, portal venous phase imaging allows better assessment because there is sufficient time for the ablation zone to mature and become better defined [1, 21, 61] .
Magnetic Resonance Imaging
The ablation zone will follow the same enhancement characteristics as appreciated on CECT; however, sensitivity in detection of residual disease is higher for contrast-enhanced MRI (89%) than for CECT (44%) [61] . MRI therefore seems well suited for immediate postablation evaluation of technical success [67, 68] .
High B-value MR DWI is increasingly used to evaluate treatment response after hepatic tumour ablation. In HCC, significant differences between pretreatment and 1e6 months post-treatment apparent diffusion coefficient (ADC) values are found, which makes the ADC of predictive value for investigating recurrent disease [69] . Usually, evidently lower ADC values in the areas of unclear hyperintense signal on T2-weighted images correlate with tumour tissue [70] .
18F-FDG PET-CT
In 18F-FDGeavid tumours, residual disease appears as an eccentric, focal, nodular area of 18F-FDG uptake against the background of low-grade homogeneous tracer distribution on 18F-FDG PET-CT imaging [70, 71] . As inflammatory changes and associated 18F-FDG tracer uptake are not appreciated within the first 24e48 hours after the ablation, early 18F-FDG PET-CT accurately predicts technical success [72, 73] . After 48 hours, increased 18F-FDG uptake in periablation inflammation and hyperemia tissue can mask foci of irregular 18F-FDG uptake of residual disease [72] .
Ablation Zone Biopsy
Relatively unknown strategy is biopsy of the margin and centre of the ablation zone immediately post-RFA [3] . It yields clinically useful information that carries prognostic significance for ablation site recurrence at the cost of an additional intervention. Ablation margins of !5 mm and a negative postprocedure biopsy predicts an ablation site recurrence risk of 3%, similar to reported marginal recurrence rates after R0 resections for CRLMs. In other words, ablation margins of <5 mm and positive postablation biopsy results will require completion procedures.
Discussion
Ablation site recurrence rates after thermal ablation are still considered relatively high (5%e10% for lesions 3 cm and >10% for lesions !3 cm in diameter) [22, 27, 74] . Successful treatment requires complete necrosis of tumour tissue including an adequate tumour-free margin in all directions. Although not widely employed or based on high-quality research evidence yet, the reviewed technological advances seem all promising in improving the safety and outcome of liver tumour ablation.
In percutaneous liver tumour ablation there is an abundant number of real-time image-guiding modalities available, of which US and CECT are still the most commonly used. Techniques capable to improve targeting are real-time image fusion and arterial cathetereassisted percutaneous ablation [27,37,49e53] . The potential of CTHA to differentiate scar tissue from ablation site recurrence (incomplete ring sign) will likely improve the outcome of reablations [56] .
In several clinical series, the use of needle navigation in percutaneous biopsies was associated with improved targeting and accuracy, a reduction in needle distance to the target, and off-path errors [28] . The use of a robotic assistance platform in simulated biopsies and radiofrequency ablation was investigated in 1 study [75] . Compared with a freehand single-pass needle insertion, use of robotic assistance was associated with lower mean needle tip-to-target distance for biopsies, and a lower average percentage of residual tumour tissue after ablation [75] . Merely having exposed a tumour to a certain amount of thermal energy for a predefined period of time represents a poor endpoint to define technical success as the ablation zone size and shape are highly dependent on tissue characteristics. Especially the incorporation of immediate postprocedure or at least early follow-up imaging (quality control) is promising and offers the opportunity to re-treat patients in case of suspected site residue. A potential algorithm for quality control after percutaneous liver tumour ablation is proposed in Figure 7 .
In terms of safety and efficacy, it remains difficult to compare the quality of available image-guiding modalities, needle tracking devices, and methods for quality control because of the large amount of image-guidance techniques, their local availability, and heterogeneous local expertise. For these reasons the method of choice should remain the method that works best for the physician performing the treatment.
Given the apparent difficulties in setting up high-quality prospective comparative studies in a rapidly changing environment, the interventional oncology society should focus on establishing national and international quality improvement guidelines and clinical registries to hold up a mirror and compare outcomes, with the intent to steadily improve the efficacy of percutaneous liver tumour ablation and hence the outcome for patients with liver tumours.
